Compare Alnylam Pharmaceuticals, Inc. (ALNY) vs Reddit Inc (RDDT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Alnylam Pharmaceuticals, Inc. vs Reddit Inc — how do they compare? Alnylam Pharmaceuticals, Inc. trades at $281.75 (market cap $39.89B), while Reddit Inc trades at $203 (market cap $37.60B). The key difference: Alnylam Pharmaceuticals, Inc. and Reddit Inc are close in size by market cap, and Reddit Inc is trading nearer its 52-week high, Alnylam Pharmaceuticals, Inc. nearer its low. Which is the better fit depends on your goals.
| ALNY | RDDT | |
|---|---|---|
Market Cap | $39.89B | $37.60B |
Sector | Health | Media |
52-Week High | $491.22 | $270.71 |
52-Week Low | $278.09 | $121.84 |
Enterprise Value | $38.15B | $34.86B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ALNY trades at $298.76, down 4.49% today, but maintains a bullish technical outlook with strong support at $290. The company reported robust revenue growth to $3.71 billion in 2025, turning profitable with net income of $313.75 million. Analyst consensus is strongly bullish with a $429.50 price target, supported by positive news on drug pipelines and AI partnerships.
Outlook remains positive driven by expanding product portfolio and strategic collaborations, though risks include clinical trial outcomes and high valuation multiples. Earnings beats in recent quarters reinforce growth trajectory, but dependence on key drug Amvuttra and competitive pressures warrant monitoring for sustained shareholder value.
Reddit (RDDT) trades at $195.42, down 2.58% amid recent profit-taking but maintains strong fundamentals with 45% revenue growth and expanding profitability. The stock shows bullish technical signals with support at $193 and resistance at $204, while analyst consensus remains strongly positive with a $229.11 price target. Recent news highlights digital advertising momentum and AI safety initiatives as key growth drivers.
Outlook remains favorable with accelerating digital ad spending and strong execution, though elevated valuation metrics and competitive pressures present risks. The upcoming Q2 2026 earnings report on July 30 will be crucial for validating growth trajectory and maintaining investor confidence in the company's expansion story.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals is a leader in the study of RNA interference (RNAi) therapeutics. RNAi is a naturally occurring biological pathway within cells for sequence-specific silencing and regulation of gene expression. Alnylam has five drugs on the market: Onpattro and Amvuttra for hATTR amyloidosis, Givlaari for acute hepatic porphyria, Oxlumo for primary hyperoxaluria type 1, and Leqvio for hypercholesterolemia.
Read more on ALNY →About Reddit Inc
Reddit Inc. operates a vast network of online communities organized around various interests, known as 'subreddits'. Functioning as a hybrid of a social media platform and a discussion forum, the company generates revenue primarily through advertising and premium subscriptions. Reddit is a major hub for user-generated content, trending news, and viral discussions, and it is a key player in the digital advertising and social media landscape.
Read more on RDDT →
